Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ORANGE SA | 3.86% | $11.17M | €37.41B | 47.49% | 65 Neutral | |
| AstraZeneca | 3.74% | $10.81M | $285.38B | 36.04% | 79 Outperform | |
| BNP Paribas | 3.61% | $10.46M | €82.87B | 31.24% | 77 Outperform | |
| NN Group N.V. | 3.43% | $9.92M | €16.25B | 45.60% | 68 Neutral | |
| Mitsubishi UFJ Financial Group | 3.25% | $9.42M | ¥28.22T | 38.72% | 76 Outperform | |
| E.ON SE | 3.18% | $9.21M | €39.99B | 31.42% | 60 Neutral | |
| Roche Holding AG | 3.12% | $9.04M | CHF250.59B | 37.98% | 73 Outperform | |
| TotalEnergies SE | 3.04% | $8.81M | €121.92B | 5.85% | 78 Outperform | |
| ING GROEP | 2.89% | $8.37M | €67.20B | 54.20% | 61 Neutral | |
| Sony | 2.88% | $8.35M | ¥27.14T | 29.05% | 73 Outperform |